⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 29, 2024Research and Practice in Thrombosis and HaemostasisOpen Access

Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications—a population-based study

Ariel Katherine Rhein Anat Rabinovich Ran Abuhasira Shir Lubaton-Barshishat Offer Erez

View Full Paper

Ask AI

Bookmark

Share

Abstract

Antiphospholipid syndrome (APS) can present with either a thromboembolic event (thrombotic APS, TAPS) or an obstetric complication (obstetric APS, OAPS). Data on long-term complications in the different APS phenotypes are limited.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rhein et al. (2024) studied this question.

synapsesocial.com/papers/68e6d055b6db64358764e063 https://doi.org/10.1016/j.rpth.2024.102430

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndromeCohort Study · 2026
2Combined Obstetric and Thrombotic Complications Are Associated with Features Suggestive of an Immune-Enriched Phenotype Among Women with Thrombotic Antiphospholipid Syndrome (APS)Cohort Study · 2026
3Antiphospholipid antibodies and antiphospholipid syndrome2024 · 3 citations
4Obstetric Morbidity and Mortality Associated with Antiphospholipid Syndrome: A Study Conducted in Tivaouane, SenegalCohort Study · 2026
5Perinatal outcomes in indian women with Antiphospholipid Antibody Syndrome (APS): Five year experience from a tertiary care centre2024 · 5 citations